{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:16:19Z","timestamp":1791994579004,"version":"4.4.0"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T00:00:00Z","timestamp":1689552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Pemphigus vulgaris (PV) is an acquired autoimmune blistering disease characterized by the production of autoantibodies targeting desmosomal cadherins, primarily desmoglein 1 and desmoglein 3, leading to acantholysis. The etiology of PV is multifactorial, including genetic susceptibility. This retrospective study aimed to evaluate the association of HLA class II alleles and PV and to examine the impact of PV-associated HLA class II alleles on the concentration of anti-desmoglein antibodies. The study group included 30 patients in whom the diagnosis of PV was confirmed by histopathological analysis, immunofluorescence findings, and ELISA testing for detecting antibodies against desmoglein 1 and desmoglein 3. HLA class II alleles were typed by polymerase chain reaction with sequence-specific primers (PCR-SSP). The control group consisted of 190 healthy volunteer blood donors. Data analysis revealed a significantly higher frequency of HLA class II alleles in our population of patients with PV, including HLA-DRB1*04:02, HLA-DRB1*14:54, HLA-DQB1*03:02, HLA-DQB1*05:03, HLA- DQA1*03:01, and HLA-DQA1*01:04, as well as a significantly lower frequency of HLA-DQA1*05:01 compared to the control group. We have also investigated the influence of risk alleles for PV, recognized in almost all study populations, HLA-DRB1*04:02 and HLA-DQB1*05:03, on the concentration of antibodies against desmogleins 1 and 3 in relation to the presence of these alleles. The results showed significantly higher levels of antibodies directed against desmoglein 3 among patients with DRB1*04:02 compared to patients without this allele. No difference was found for anti-desmoglein 1 antibodies. Regarding DQB1*05:03 allele, statistical analysis showed no differences in the concentration of anti-desmoglein antibodies in patients carrying this allele versus those without it.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1200992","type":"journal-article","created":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T03:14:50Z","timestamp":1689563690000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["HLA class II antigens in Croatian patients with pemphigus vulgaris and their correlation with anti-desmoglein antibodies"],"prefix":"10.3389","volume":"14","author":[{"given":"Ines","family":"Lako\u0161 Juki\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mislav","family":"Mokos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Branka","family":"Marinovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2011.07.003","article-title":"Autoimmune blistering diseases: incidence and treatment in Croatia","volume":"29","author":"Marinovic","year":"2011","journal-title":"Dermatol Clin"},{"key":"B2","doi-asserted-by":"crossref","DOI":"10.2340\/0001555562491496","article-title":"Pemphigus: an epidemiological study of patients treated in Finnish hospitals between 1969 and 1978","volume":"62","author":"Hietanen","year":"1982","journal-title":"Acta Derm Venereol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(74)90365-x","article-title":"Pemphigus vulgaris: incidence in jews of different ethnic groups, according to age, sex, and initial lesion","volume":"38","author":"Pisanti","year":"1974","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0140-6736(05)66829-8","article-title":"Pemphigus","volume":"366","author":"Bystryn","year":"2005","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"crossref","DOI":"10.1001\/archderm.1980.01640330073017","article-title":"Pemphigus in Hartford county, Connecticut, from 1972 to 1977","volume":"116","author":"Simon","year":"1980","journal-title":"Arch Dermatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2009.10.009","article-title":"Geoepidemiologic considerations of auto-immune pemphigus","volume":"9","author":"Meyer","year":"2010","journal-title":"Autoimmun Rev"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-018-8986-7","article-title":"Pemphigus group: overview, epidemiology, mortality, and comorbidities","volume":"66","author":"Kridin","year":"2018","journal-title":"Immunol Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1046\/j.1468-3083.2002.00384.x","article-title":"Increased incidence of pemphigus vulgaris in southern europeans living in Germany compared with native germans","volume":"16","author":"Hahn-Ristic","year":"2002","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00226","article-title":"The genetics of pemphigus vulgaris","volume":"5","author":"Vodo","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"B10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1006\/jaut.2000.0388","article-title":"HLA class II polymorphism contributes to specify desmoglein derived peptides in pem-phigus vulgaris and pemphigus foliaceus","volume":"15","author":"Loiseau","year":"2000","journal-title":"J Autoimmun"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.1996.tb02689.x","article-title":"HLA haplotypes and class II molecular alleles in sardinian and Italian patients with pemphigus vul-garis","volume":"48","author":"Carcassi","year":"1996","journal-title":"Tissue Antigens"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.1999.00626.x","article-title":"Common human leukocyte antigen alleles in pemphigus vulgaris and pemphigus fo-liaceus Italian patients","volume":"113","author":"Lombardi","year":"1999","journal-title":"J Invest Dermatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.1998.tb03043.x","article-title":"Distribution of HLA class II alleles among Spanish patients with pemphigus vulgaris","volume":"52","author":"Gonz\u00e1lez-Escribano","year":"1998","journal-title":"Tissue Antigens"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2005.09.003","article-title":"Disease relevant HLA class II alleles isolated by genotypic, haplotypic, and sequence analysis in north American caucasians with pemphigus vulgaris","volume":"67","author":"Lee","year":"2006","journal-title":"Hum Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jaut.2016.04.007","article-title":"Differential HLA class I and class II associations in pemphigus foliaceus and pemphigus vulgaris patients from a prevalent southeastern Brazilian region","volume":"72","author":"Brochado","year":"2016","journal-title":"J Autoimmun"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/iji.12052","article-title":"High susceptibility to pemphigus vulgaris due to HLA-DRB1*14:54 in the Slovak population","volume":"40","author":"P\u00e1rnick\u00e1","year":"2013","journal-title":"Int J Immunogenet"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.xjidi.2021.100004","article-title":"Epidemiology of pemphigus","volume":"1","author":"Kridin","year":"2021","journal-title":"JID Innov"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.19.7658","article-title":"Major histo-compatibility complex haplotype studies in ashkenazi Jewish patients with pemphi-gus vulgaris","volume":"87","author":"Ahmed","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"B19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.autrev.2004.05.002","article-title":"The immunogenetics of pemphigus vulgaris","volume":"4","author":"Gazit","year":"2005","journal-title":"Autoimmun Rev"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12337585","article-title":"HLA-DRB1*04 and DRB1*14 alleles are associated with susceptibility to pemphigus among Japanese","volume":"109","author":"Miyagawa","year":"1997","journal-title":"J Invest Dermatol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.1996.tb02545.x","article-title":"Molecular analysis of HLA DRB1 and DQB1 in Italian patients with pemphigus vulgaris","volume":"47","author":"Lombardi","year":"1996","journal-title":"Tissue Antigens"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/s0198-8859(97)00203-6","article-title":"Pemphigus vulgaris autoantibody response is linked to HLA-DQB1*0503 in Pakistani patients","volume":"57","author":"Delgado","year":"1997","journal-title":"Hum Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2009.241","article-title":"Pemphigus vulgaris in white europeans is linked with HLA class II allele HLA DRB1*1454 but not DRB1*1401","volume":"130","author":"Saha","year":"2010","journal-title":"J Invest Dermatol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3109\/08916934.2012.702811","article-title":"Specific immunoglobulin isotypes correlate with disease activity, morphology, duration and HLA association in pemphigus vulgaris","volume":"45","author":"Dhandha","year":"2012","journal-title":"Autoimmunity"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12016-017-8662-z","article-title":"Pemphigus: a comprehensive review on pathogenesis, clinical presentation and novel therapeutic approaches","volume":"54","author":"Pollmann","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2011.11.012","article-title":"Geoepidemiology, gender and autoimmune disease","volume":"11","author":"Moroni","year":"2012","journal-title":"Autoimmun Rev"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2004.02292","article-title":"Spectrum of autoimmune bullous diseases in Kuwait","volume":"43","author":"Nanda","year":"2004","journal-title":"Int J Dermatol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.2001.01247","article-title":"The incidence of pemphigus in the southern region of Saudi Arabia","volume":"40","author":"Tallab","year":"2001","journal-title":"Int J Dermatol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1080\/08916930600971497","article-title":"Immunogenetics of pemphigus: an update","volume":"39","author":"Tron","year":"2006","journal-title":"Autoimmunity"},{"key":"B30","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1600-0714.1989.tb00733.x","article-title":"Familial pemphigus vulgaris with oral manifestations affecting two Greek families","volume":"18","author":"Laskaris","year":"1989","journal-title":"J Oral Pathol Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1080\/00015550152384380","article-title":"Pemphigus vulgaris in two sisters","volume":"81","author":"Stavropoulos","year":"2001","journal-title":"Acta Derm Venereol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1991.tb03873.x","article-title":"Pemphigus in families","volume":"30","author":"Feinstein","year":"1991","journal-title":"Int J Dermatol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/s0190-9622(97)70324-4","article-title":"Circulating pemphigus IgG in families of patients with pemphigus: comparison of indirect immunofluorescence, direct immunofluorescence, and immunoblotting","volume":"36","author":"Brandsen","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1084\/jem.177.2.419","article-title":"Linkage of pemphigus vulgaris antibody to the major histocompatibility complex in healthy relatives of patients","volume":"177","author":"Ahmed","year":"1993","journal-title":"J Exp Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1973.01620270029007","article-title":"Increased frequency of HL-A10 in pemphigus vulgaris","volume":"108","author":"Krain","year":"1973","journal-title":"Arch Dermatol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2012.11040","article-title":"Association between HLA-DRB1 polymorphisms and pemphigus vulgaris: a meta-analysis","volume":"167","author":"Yan","year":"2012","journal-title":"Br J Dermatol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1064073","article-title":"Patient genetics shape the autoimmune response in the blistering skin disease pemphigus vulgaris","volume":"13","author":"Baker","year":"2023","journal-title":"Front Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-008-9244-x","article-title":"(DRB, DQA1 and DQB1) allele and haplotype frequencies in the patients with pemphigus vulgaris","volume":"29","author":"Shams","year":"2009","journal-title":"J Clin Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.13577","article-title":"Study of the association between human leukocyte antigens (HLA) and pemphigus vulgaris in Brazilian patients","volume":"56","author":"Gil","year":"2017","journal-title":"Int J Dermatol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1080\/08820139.2017.1385622","article-title":"Association between HLA-DQB1 polymorphisms and pemphigus vulgaris: a meta-analysis","volume":"47","author":"Li","year":"2018","journal-title":"Immunol Invest"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.2007.00826.x","article-title":"HLA-DRB1*0402 haplotypes without DQB1*0302 in Venezuelan patients with pemphigus vulgaris","volume":"69","author":"S\u00e1enz-Cantele","year":"2007","journal-title":"Tissue Antigens"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.1.635","article-title":"Dichotomy of au-toreactive Th1 and Th2 cell responses to desmoglein 3 in patients with pemphigus vulgaris (PV) and healthy carriers of PV-associated HLA class II alleles","volume":"170","author":"Veldman","year":"2003","journal-title":"J Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/s0198-8859(97)00182-1","article-title":"Identical MHC markers in non-Jewish Iranian and ashkenazi Jewish patients with pemphigus vulgaris: possible common central Asian ancestral origin","volume":"57","author":"Mobini","year":"1997","journal-title":"Hum Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.02552.x","article-title":"HLA-DRB1*0701 and DRB1*1401 are associated with genetic susceptibility to psoriasis vulgaris in a Taiwanese population","volume":"139","author":"Jee","year":"1998","journal-title":"Br J Dermatol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.12418","article-title":"HLA DRB1* and DQB1* alleles are associated with disease severity in patients with pemphigus vulgaris","volume":"54","author":"Svecova","year":"2015","journal-title":"Int J Dermatol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1172\/JCI119130","article-title":"Development and characterization of desmoglein-3 specific T cells from patients with pemphigus vulgaris","volume":"99","author":"Lin","year":"1997","journal-title":"J Clin Invest"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.6.3883","article-title":"T Cell recognition of desmoglein 3 peptides in patients with pemphigus vulgaris and healthy individuals","volume":"172","author":"Veldman","year":"2004","journal-title":"J Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3109\/08916939908993852","article-title":"HLA class II restriction of autoreactive T cell responses in pemphigus vulgaris: review of the literature and potential applications for the development of a specific immunotherapy","volume":"30","author":"Riechers","year":"1999","journal-title":"Autoimmunity"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1172\/JCI28547","article-title":"T Cell control in autoimmune bullous skin disorders","volume":"116","author":"Hertl","year":"2006","journal-title":"J Clin Invest"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1401081","article-title":"Pathogenic IgG antibodies against desmogle-in 3 in pemphigus vulgaris are regulated by HLA-DRB1*04:02-restricted T cells","volume":"193","author":"Eming","year":"2014","journal-title":"J Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-011-9597-4","article-title":"Cognate Th2-b cell interaction is essential for the autoantibody production in pemphigus vulgaris","volume":"32","author":"Zhu","year":"2012","journal-title":"J Clin Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.182.3.1740","article-title":"A single helper T cell clone is sufficient to commit polyclonal naive b cells to produce pathogenic IgG in experimental pemphigus vulgaris","volume":"182","author":"Takahashi","year":"2009","journal-title":"J Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2002.04838","article-title":"Monitoring disease activity in pemphigus with enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3","volume":"147","author":"Cheng","year":"2002","journal-title":"Br J Dermatol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01418","article-title":"Pemphigus: current and future therapeutic strategies","volume":"10","author":"Didona","year":"2019","journal-title":"Front Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(91)90360","article-title":"Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion","volume":"67","author":"Amagai","year":"1991","journal-title":"Cell"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1200992\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,17]],"date-time":"2023-12-17T00:44:57Z","timestamp":1702773897000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1200992\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,17]]},"references-count":55,"alternative-id":["10.3389\/fimmu.2023.1200992"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1200992","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,17]]},"article-number":"1200992"}}